S
Stephen G. Pauker
Researcher at Tufts Medical Center
Publications - 269
Citations - 24203
Stephen G. Pauker is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Decision analysis & Cost effectiveness. The author has an hindex of 70, co-authored 269 publications receiving 23206 citations. Previous affiliations of Stephen G. Pauker include University of Illinois at Chicago & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Foot Infections in Diabetic Patients: Decision and Cost-effectiveness Analyses
Mark H. Eckman,Sheldon Greenfield,William C. Mackey,John B. Wong,Sherrie H. Kaplan,Lisa M. Sullivan,Kim Dukes,Stephen G. Pauker +7 more
TL;DR: In patients without systemic toxicity, a 10-week course of culture-guided oral antibiotic therapy following surgical débridement may be as effective as and less costly than other approaches.
Journal ArticleDOI
Variations in Length of Stay and Outcomes for Six Medical and Surgical Conditions in Massachusetts and California
Paul D. Cleary,Sheldon Greenfield,Albert G. Mulley,Stephen G. Pauker,Steven A. Schroeder,Lewis Wexler,Barbara J. McNeil +6 more
TL;DR: Length of stay did not have a significant impact on deaths, functional status after hospital discharge, the probability of readmission, or patient satisfaction with hospital care, and more research is needed to determine the medical practices related to variations in lengths of stay.
Journal ArticleDOI
Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
TL;DR: This chapter about antithrombotic therapy for valvular heart disease is part of the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Journal ArticleDOI
Cost-effectiveness of Interferon-α2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B
TL;DR: This study projected the expected clinical and economic outcomes of patients with chronic hepatitis B and estimated the cost-effectiveness of interferon therapy and calculated the quality-adjusted life expectancy for each cohort by using a Markov computer simulation.
Journal ArticleDOI
Grades of Recommendation for Antithrombotic Agents
TL;DR: Whatever the grade of recommendation, clinicians must bring their judgment considering local and individual patient circumstances, and patient values, to bear in making individual decisions, and should place progressively greater weight on expert recommendations as they move from 2C to 1A.